These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32133149)

  • 1.
    Gontika M; Skarlis C; Artemiadis A; Pons R; Mastroyianni S; Vartzelis G; Theodorou V; Kilindireas K; Stefanis L; Dalakas M; Chrousos G; Anagnostouli M
    Mult Scler J Exp Transl Clin; 2020; 6(1):2055217320908046. PubMed ID: 32133149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile.
    Skarlis C; Markoglou N; Gontika M; Artemiadis A; Pons MR; Stefanis L; Dalakas M; Chrousos G; Anagnostouli M
    Neurol Sci; 2024 May; ():. PubMed ID: 38819529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data.
    Gontika M; Skarlis C; Markoglou N; Evangelopoulos ME; Velonakis G; Chrousos GP; Dalakas M; Stefanis L; Anagnostouli M
    Neurol Sci; 2022 Apr; 43(4):2641-2649. PubMed ID: 34596776
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Anagnostouli M; Artemiadis A; Gontika M; Skarlis C; Markoglou N; Katsavos S; Kilindireas K; Doxiadis I; Stefanis L
    Brain Sci; 2020 Jun; 10(6):. PubMed ID: 32560041
    [No Abstract]   [Full Text] [Related]  

  • 5. Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions-a single-center retrospective observational study.
    Gontika M; Skarlis C; Markoglou N; Tzanetakos D; Vakrakou A; Toulas P; Koutsis G; Evangelopoulos ME; Pons R; Dardiotis E; Chrousos G; Dalakas M; Stefanis L; Anagnostouli M
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Aug; 395(8):933-943. PubMed ID: 35471586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of Apolipoprotein E gene variants in pediatric-onset multiple sclerosis: Possible association with disease susceptibility and its clinical characteristics, in a Hellenic cohort.
    Skarlis C; Markoglou N; Artemiadis A; Gontika M; Koutsis G; Chrousos G; Anagnostouli M
    Mult Scler Relat Disord; 2024 Oct; 90():105797. PubMed ID: 39146895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
    Ziaei A; Solomon O; Casper TC; Waltz M; Weinstock-Guttman B; Aaen G; Wheeler Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Waldman AT; Krupp L; James JA; Hart J; Barcellos LF; Waubant E
    Mult Scler; 2024 Mar; 30(3):308-315. PubMed ID: 38332747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution.
    Ziaei A; Lavery AM; Shao XM; Adams C; Casper TC; Rose J; Candee M; Weinstock-Guttman B; Aaen G; Harris Y; Graves J; Benson L; Gorman M; Rensel M; Mar S; Lotze T; Greenberg B; Chitnis T; Hart J; Waldman AT; Barcellos LF; Waubant E
    Mult Scler; 2022 Aug; 28(9):1330-1339. PubMed ID: 35000467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Disanto G; Magalhaes S; Handel AE; Morrison KM; Sadovnick AD; Ebers GC; Banwell B; Bar-Or A;
    Neurology; 2011 Mar; 76(9):781-6. PubMed ID: 21288988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DRB1 differences in allelic distribution between familial and sporadic multiple sclerosis in a Hellenic cohort.
    Katsavos S; Artemiadis A; Gontika M; Skarlis C; Markoglou N; Davaki P; Stamboulis E; Kilindireas K; Stefanis L; Anagnostouli M
    Postgrad Med; 2019 Sep; 131(7):490-495. PubMed ID: 31408393
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic risk factors for pediatric-onset multiple sclerosis.
    Gianfrancesco MA; Stridh P; Shao X; Rhead B; Graves JS; Chitnis T; Waldman A; Lotze T; Schreiner T; Belman A; Greenberg B; Weinstock-Guttman B; Aaen G; Tillema JM; Hart J; Caillier S; Ness J; Harris Y; Rubin J; Candee M; Krupp L; Gorman M; Benson L; Rodriguez M; Mar S; Kahn I; Rose J; Roalstad S; Casper TC; Shen L; Quach H; Quach D; Hillert J; Hedstrom A; Olsson T; Kockum I; Alfredsson L; Schaefer C; Barcellos LF; Waubant E;
    Mult Scler; 2018 Dec; 24(14):1825-1834. PubMed ID: 28980494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages and HLA-Class II Alleles in Multiple Sclerosis: Insights in Therapeutic Dynamics.
    Prapas P; Anagnostouli M
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
    Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
    Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
    J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.